Eligi
Med
Base de datos
Seguridad
Sobre EligiMed
Contacto
Contáctenos
Ensayos Clínicos | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
A NOVEL Observational longiTudinal studY on Patients With Asthma and/or COPD to Describe Patient Characteristics, Treatment Patterns and the Burden of Illness Over Time and to Identify Phenotypes and Endotypes.
OBSERVATIONAL
Inicio: 25 de jul de 2016
ID: NCT02760329
Completado
ClinicalTrials.gov
Ambulatory Laparoscopic Inguinal Hernioplasty: Feasibility and Cost Minimization Analysis in a South American Hospital
OBSERVATIONAL
Inicio: 1 de ago de 2015
ID: NCT04504461
Completado
Fase 3
ClinicalTrials.gov
Phase III, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy (Induction of Remission) and Safety of Etrolizumab Compared With Adalimumab and Placebo in Patients With Moderate to Severe Ulcerative Colitis Who Are Naive to TNF Inhibitors
INTERVENTIONAL
Inicio: 14 de nov de 2014
ID: NCT02171429
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Open Label, Randomized, Comparative Study Of CP-675,206 And Either Dacarbazine Or Temozolomide In Patients With Advanced Melanoma
INTERVENTIONAL
Inicio: 1 de mar de 2006
ID: NCT00257205
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Placebo- Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
INTERVENTIONAL
Inicio: 8 de jul de 2019
ID: NCT03899259
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, International, Randomized, Active Comparator-controlled, Double-blind, Double-dummy, Parallel-group, 2-arm, Phase 3 Study to Compare the Efficacy and Safety of the Oral FXIa Inhibitor Asundexian (BAY 2433334) With Apixaban for the Prevention of Stroke or Systemic Embolism in Male and Female Participants Aged 18 Years and Older With Atrial Fibrillation at Risk for Stroke
INTERVENTIONAL
Inicio: 5 de dic de 2022
ID: NCT05643573
Completado
Fase 2
ClinicalTrials.gov
A Phase I/IIa Open-label Investigation of the Safety and Effectiveness of DIABECELL® [Immunoprotected (Alginate-Encapsulated) Porcine Islets for Xenotransplantation] in Patients With Type 1 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de ago de 2011
ID: NCT01739829
Completado
ClinicalTrials.gov
Anti-tnf Inhibitor Antibody-mediated Blockade Of Drug Efficacy In Rheumatoid Arthritis (Antibody-ra)
OBSERVATIONAL
Inicio: 1 de ene de 2014
ID: NCT01981473
Completado
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 Monotherapy and MEDI4736 in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
INTERVENTIONAL
Inicio: 9 de sept de 2015
ID: NCT02369874
Completado
Fase 3
ClinicalTrials.gov
An Open-Label, Randomized, MultiCenter Study to Evaluate the Use of Zolendronic Acid in the Prevention of Cancer Treatment-Related Bone Loss in Postmenopausal Women With Estrogen Positive and/or Progesterone Positive Breast Cancer Receiving Letrozole as Adjuvant Therapy
INTERVENTIONAL
Inicio: 1 de may de 2003
ID: NCT00171340
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Cefepime-AAI101 Compared to Piperacillin/Tazobactam in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis.
INTERVENTIONAL
Inicio: 24 de sept de 2018
ID: NCT03687255
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Open-Label Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
INTERVENTIONAL
Inicio: 24 de ago de 2018
ID: NCT03467958
Completado
Fase 3
ClinicalTrials.gov
An 18-Month Open Label Extension Study (OLES) of the Safety and Efficacy of Recombinant Human Parathyroid Hormone, rhPTH(1-84), ALX1-11, in Women With Postmenopausal Osteoporosis Who Participated in Protocol ALX1-11-93001 (TOP Study)
INTERVENTIONAL
Inicio: 16 de oct de 2001
ID: NCT00172133
Desconocido
ClinicalTrials.gov
Recruitment Assessment in Patients With Acute Respiratory Distress Syndrome and Covid-19
OBSERVATIONAL
Inicio: 7 de mar de 2022
ID: NCT05248243
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study of Weekly Paclitaxel With or Without Ramucirumab (IMC-1121B) Drug Product in Patients With Metastatic Gastric Adenocarcinoma, Refractory to or Progressive After First-Line Therapy With Platinum and Fluoropyrimidine
INTERVENTIONAL
Inicio: 1 de dic de 2010
ID: NCT01170663
Terminado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Safety and Efficacy of OMS721 in Patients With Immunoglobulin A (IgA) Nephropathy (ARTEMIS - IGAN)
INTERVENTIONAL
Inicio: 5 de abr de 2018
ID: NCT03608033
Completado
Fase 3
ClinicalTrials.gov
Open-label, Randomized, Controlled, Multicenter Phase III Study Investigating Cetuximab in Combination With Capecitabine (Xeloda, X) and Cisplatin (P) Versus XP Alone as First-line Treatment for Subjects With Advanced Gastric Adenocarcinoma Including Adenocarcinoma of the Gastroesophageal Junction
INTERVENTIONAL
Inicio: 1 de jun de 2008
ID: NCT00678535
Completado
Fase 3
ClinicalTrials.gov
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects With Symptomatic Left Ventricular Systolic Dysfunction and Anemia
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00358215
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
INTERVENTIONAL
Inicio: 27 de sept de 2016
ID: NCT02876835
Completado
Fase 1
ClinicalTrials.gov
A Phase 1 Pharmacokinetic Drug-Drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers
INTERVENTIONAL
Inicio: 1 de oct de 2014
ID: NCT03892213
Anterior
1
...
415
416
417
...
434
Siguiente
Filtros